Xiaoshuang Zhou

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Vascular Endothelial Growth Factor

Ejection Fraction

Acute Kidney Injury

Top Venues

Diabetes, metabolic syndrome and obesity : targets and therapy

Drug design, development and therapy

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Dongna Hui, Fang Zhang, Yuanyue Lu, Huiqiang Hao, Shuangshuang Tian, Xiuzhao Fan, Yanqin Liu, Xiaoshuang Zhou, Rongshan Li
A Multifactorial Risk Score System for the Prediction of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Jia Yao, Yaqiu Ji, Tian Liu, Jinjia Bai, Han Wang, Ruoyu Yao, Juan Wang, Xiaoshuang Zhou
Single-Cell RNA Sequencing Shows T-Cell Exhaustion Landscape in the Peripheral Blood of Patients with Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure. Gut and liver (2023)
Dongna Hui, Fang Zhang, Yuanyue Lu, Huiqiang Hao, Shuangshuang Tian, Xiuzhao Fan, Yanqin Liu, Xiaoshuang Zhou, Rongshan Li
A Multifactorial Risk Score System for the Prediction of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus. Diabetes, metabolic syndrome and obesity : targets and therapy 16 (2023)
Rui Zhang, Jing Ji, Xiaoshuang Zhou, Rong-Shan Li
Irisin Pretreatment Protects Kidneys against Acute Kidney Injury Induced by Ischemia/Reperfusion via Upregulating the Expression of Uncoupling Protein 2. BioMed research international 2020 (2020)
Yanhong Wang, Yang Mi, Jihua Tian, Xi Qiao, Xiaole Su, Jing Kang, Zhijing Wu, Guiqing Wang, Xiaoshuang Zhou, Yun Zhou, Rongshan Li
Intermedin Alleviates Renal Ischemia-Reperfusion Injury and Enhances Neovascularization in Wistar Rats. Drug design, development and therapy 14 (2020)